MARKET

CLDWW

CLDWW

Calidi Biotherapeutics
OTCPK
0.0060
NaN%
Closed 09:30 03/05 EST
OPEN
--
PREV CLOSE
0.0060
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.208
52 WEEK LOW
0.0051
MARKET CAP
--
P/E (TTM)
-0.0006
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLDWW last week (0908-0912)?
Weekly Report · 09/15/2025 11:59
Weekly Report: what happened at CLDWW last week (0901-0905)?
Weekly Report · 09/08/2025 12:01
Weekly Report: what happened at CLDWW last week (0825-0829)?
Weekly Report · 09/01/2025 11:55
Weekly Report: what happened at CLDWW last week (0818-0822)?
Weekly Report · 08/25/2025 12:10
Weekly Report: what happened at CLDWW last week (0811-0815)?
Weekly Report · 08/18/2025 11:58
Weekly Report: what happened at CLDWW last week (0804-0808)?
Weekly Report · 08/11/2025 12:08
Weekly Report: what happened at CLDWW last week (0728-0801)?
Weekly Report · 08/04/2025 12:11
Weekly Report: what happened at CLDWW last week (0721-0725)?
Weekly Report · 07/28/2025 12:12
More
About CLDWW
Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's novel stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Its clinical-stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses. Its preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach shall potentially treat, or even prevent, metastatic disease. Its product candidates include CLD-101 for Recurrent HGG; CLD-201 for Advanced Solid Tumors, and CLD-400 (RTNova) for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline product candidates, the Company's is also engaged in discovery research of CLD-301 (AAA) for multiple Indications.

Webull offers Calidi Biotherapeutics Inc stock information, including OTCPK: CLDWW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLDWW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLDWW stock methods without spending real money on the virtual paper trading platform.